SCOPUS 정보 검색 플랫폼

Volumn 165, Issue 4, 2011, Pages 922-923

Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL -1) in two patients with tuberous sclerosis

(3) Mutizwa, M M a Berk, D R a Anadkat, M J a

a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; RAPAMYCIN;

ADOLESCENT; ADULT; APPLICATION SITE IRRITATION; CANCER CHEMOTHERAPY; CASE REPORT; CORTICOSTEROID THERAPY; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FACE ANGIOFIBROMA; FACE TUMOR; FEMALE; FOLLOW UP; HEMANGIOFIBROMA; HUMAN; LETTER; NEVUS; PRIORITY JOURNAL; SKIN IRRITATION; TOPICAL TREATMENT; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANGIOFIBROMA; ANTIBIOTICS, ANTINEOPLASTIC; FACIAL NEOPLASMS; FEMALE; HUMANS; OFF-LABEL USE; SIROLIMUS; TUBEROUS SCLEROSIS;

EID: 80053550251 PISSN: 00070963 EISSN: 13652133 Source Type: Journal
DOI: 10.1111/j.1365-2133.2011.10476.x Document Type: Letter

Times cited : (50)

References (7)

1
- 49649118165
- Tuberous sclerosis
- Curatolo P, Bombardieri R, Jozwiak S,. Tuberous sclerosis. Lancet 2008; 372: 657-68.
- (2008) Lancet , vol.372 , pp. 657-668
- Curatolo, P.¹ Bombardieri, R.² Jozwiak, S.³

2
- 34447272449
- Tuberous sclerosis complex: Advances in diagnosis, genetics, and management
- DOI 10.1016/j.jaad.2007.05.004, PII S0190962207008420
- Schwartz RA, Fernandez G, Kotulska K, Jozwiak S,. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 2007; 57: 189-202. (Pubitemid 47048880)
- (2007) Journal of the American Academy of Dermatology , vol.57 , Issue.2 , pp. 189-202
- Schwartz, R.A.¹ Fernandez, G.² Kotulska, K.³ Jozwiak, S.⁴

3
- 38049169559
- Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
- Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140-51.
- (2008) N Engl J Med , vol.358 , pp. 140-151
- Bissler, J.J.¹ McCormack, F.X.² Young, L.R.³

4
- 33644827461
- Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
- DOI 10.1002/ana.20784
- Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006; 59: 490-8. (Pubitemid 43358069)
- (2006) Annals of Neurology , vol.59 , Issue.3 , pp. 490-498
- Franz, D.N.¹ Leonard, J.² Tudor, C.³ Chuck, G.⁴ Care, M.⁵ Sethuraman, G.⁶ Dinopoulos, A.⁷ Thomas, G.⁸ Crone, K.R.⁹

5
- 47549093135
- The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
- DOI 10.1111/j.1365-2133.2008.08677.x
- Hofbauer GF, Marcollo-Pini A, Corsenca A, et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br J Dermatol 2008; 159: 473-5. (Pubitemid 352009863)
- (2008) British Journal of Dermatology , vol.159 , Issue.2 , pp. 473-475
- Hofbauer, G.F.L.¹ Marcollo-Pini, A.² Corsenca, A.³ Kistler, A.D.⁴ French, L.E.⁵ Wuthrich, R.P.⁶ Serra, A.L.⁷

6
- 77954830298
- A novel approach to facial angiofibromas in tuberous sclerosis
- Haemel AK, O'Brian AL, Teng JM,. A novel approach to facial angiofibromas in tuberous sclerosis. Arch Dermatol 2010; 146: 715-18.
- (2010) Arch Dermatol , vol.146 , pp. 715-718
- Haemel, A.K.¹ O'Brian, A.L.² Teng, J.M.³

7
- 79956101097
- Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin
- (in press).
- Kaufman McNamara E, Curtis AR, Fleischer AB Jr,. Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin. J Dermatolog Treat (in press).
- J Dermatolog Treat
- Kaufman McNamara, E.¹ Curtis, A.R.² Fleischer, A.B.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.